{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:35Z","timestamp":1791352295480,"version":"4.3.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T00:00:00Z","timestamp":1288828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T00:00:00Z","timestamp":1288828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1111\/j.1365-2133.2010.10060.x","type":"journal-article","created":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T03:54:13Z","timestamp":1285214053000},"page":"1323-1329","source":"Crossref","is-referenced-by-count":60,"title":["A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms"],"prefix":"10.1093","volume":"163","author":[{"given":"E.J.","family":"McGrath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gillison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Darvay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Skevington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,11,4]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archderm.138.12.1584","article-title":"Acne vulgaris: a disease of Western civilization","volume":"138","author":"Cordain","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","article-title":"Prevalence of facial acne vulgaris in late adolescence and in adults","volume":"i","author":"Cunliffe","year":"1979","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2165\/00019053-199406020-00003","article-title":"Effect of isotretinoin on the quality of life of patients with acne","volume":"6","author":"Simpson","year":"1994","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2133.1999.02768.x","article-title":"The quality of life in acne: a comparison with general medical conditions using generic questionnaires","volume":"140","author":"Mallon","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2006.07185.x","article-title":"A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases","volume":"155","author":"Beattie","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2004.01678.x","article-title":"Quality of life issues for South Africans with acne vulgaris","volume":"30","author":"Mosam","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2133.1998.02511.x","article-title":"Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.279.14.1057-JMN0408-2-1","article-title":"Acne drug depression warnings highlight need for expert care","volume":"279","author":"Lamberg","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0190-9622(88)70078-X","article-title":"Adverse reactions to isotretinoin","volume":"18","author":"Bigby","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/dtb.2003.411076","article-title":"Acne, isotretinoin and depression","volume":"41","year":"2003","journal-title":"Drug Ther Bull"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1067\/mjd.2001.118233","article-title":"Suicide, depression, and isotretinoin: is there a causal link?","volume":"45","author":"Jacobs","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.sder.2005.04.003","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"24","author":"Marqueling","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1440-0960.2002.00612.x","article-title":"Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy","volume":"43","author":"Ng","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2230.1992.tb02521.x","article-title":"Practical use of a disability index in the routine management of acne","volume":"17","author":"Motley","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1468-3083.2005.01344.x","article-title":"Quality of life and acne in Scottish adolescent schoolchildren: use of the Children\u2019s Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI)","volume":"20","author":"Walker","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0277-9536(98)00009-4","article-title":"The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties","volume":"46","author":"The WHOQOL Group","year":"1998","journal-title":"Soc Sci Med"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization","volume":"41","author":"The WHOQOL Group","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12098-010-0041-1","article-title":"Validation of WHO QOL-BREF instrument in Indian adolescents","volume":"77","author":"Agnihotri","year":"2010","journal-title":"Indian J Pediatr"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2133.2005.07045.x","article-title":"How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100","volume":"154","author":"Skevington","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB24|cit24","unstructured":"British Association of Dermatologists http:\/\/www.bad.org.uk\/"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0033291798006667","article-title":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","volume":"28","author":"The WHOQOL Group","year":"1998","journal-title":"Psychol Med"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"WHOQOL Group. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB27|cit27","article-title":"Expecting a good quality of life in health. Assessing people with diverse diseases, conditions and health, using the WHOQOL-BREF","author":"Skevington","journal-title":"Health Expect"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09546639809160698","article-title":"The Leeds revised acne grading system","volume":"9","author":"O\u2019Brien","year":"1998","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00004583-199805000-00012","article-title":"Prediction of major depression and dysthymia from CES-D scores among ethnic minority adolescents","volume":"37","author":"Prescott","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/00005053-198012000-00005","article-title":"Children\u2019s symptom and social functioning self-report scales. Comparison of mothers\u2019 and children\u2019s reports","volume":"168","author":"Weissman","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0165-1781(01)00360-2","article-title":"Measurement adequacy of the CES-D among a sample of older African-Americans","volume":"109","author":"Long Foley","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/art.23329","article-title":"Canadian Scleroderma Research Group. Reliability and validity of the Center for Epidemiologic Studies depression scale in patients with systemic sclerosis","volume":"59","author":"Thombs","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1192\/bjp.178.3.261","article-title":"Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100","volume":"178","author":"Skevington","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-8-2","article-title":"Isotretinoin and psychopathology: a review","volume":"8","author":"Kontaxakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1300998","article-title":"Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice","volume":"31","author":"O\u2019Reilly","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3181\/0706-MR-158","article-title":"Retinoid-mediated regulation of mood; possible cellular mechanisms","volume":"233","author":"O\u2019Reilly","year":"2008","journal-title":"Exp Biol Med"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00213-004-1950-3","article-title":"Implications of genetic research on the role of serotonin in depression; emphasis on the serotonin type 1(A) receptor and the serotonin transporter","volume":"174","author":"Neumeister","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.v69n0403","article-title":"Isotretinoin and the risk of depression in patients with acne vulgaris; a case-cross-over study","volume":"69","author":"Azoulay","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaad.2008.07.013","article-title":"Self-esteem and body satisfaction among late adolescents with acne: results from a population survey","volume":"59","author":"Dalgard","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-4632.2009.03806.x","article-title":"Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents","volume":"48","author":"Keymak","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1346-8138.2009.00635.x","article-title":"Changes of psychological parameters and their relationships by oral isotretinoin in acne patients","volume":"36","author":"Hahm","year":"2009","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.10060.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1468-3083.2009.03313.x","article-title":"Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts","volume":"23","author":"Rehn","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10060.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.10060.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.10060.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:50:15Z","timestamp":1676364615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/163\/6\/1323\/6643906"}},"subtitle":["Effects of isotretinoin on QoL and depressive symptoms"],"short-title":[],"issued":{"date-parts":[[2010,11,4]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10060.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,4]]}}}